Evergreen Therapeutics   Report issue

For profit Phase 2 Phase 3
Founded: Bethesda MD United States (2019)

Organization Overview

First Clinical Trial
2020
NCT04561180
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Evergreen Therapeutics, Inc.